title: [Cervical cancer screening in Switzerland - current practice and future challenges].
abstract: At the beginning of the 20th Century, cervical cancer was the leading cause of death from cancer in women. A marked decline in cervical cancer has been observed since the 1960s, in parallel with the introduction of the Papanicolau (Pap) test as a cytological screening method. Today, Pap smear screening is still the most widely used tool for cervical cancer prevention. Testing for human papillomavirus (HPV) in cervical specimens or a combination of Pap and HPV testing are also now available. In this article we compare current guidelines for cervical cancer screening in Switzerland with those in other European countries. In view of the opportunities offered by HPV testing and, since 2008, HPV vaccination, current guidelines for cervical cancer screening should be updated. Both the choice of screening tests and general organization of cervical cancer screening should be reviewed.
authors.affiliation: Hôpitaux Universitaires de Genève, Genf. sarah.untiet@hcuge.ch
authors.forename: Sarah
authors.initials: S
authors.lastname: Untiet
authors.forename: Nicole
authors.initials: N
authors.lastname: Schmidt
authors.forename: Nicola
authors.initials: N
authors.lastname: Low
authors.forename: Patrick
authors.initials: P
authors.lastname: Petignat
mesh_terms: D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D008403:Mass Screening / Q000639:trends*; D030361:Papillomavirus Infections / Q000175:diagnosis* / Q000517:prevention & control*; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis* / Q000517:prevention & control*